Alessandro Bertero

Alessandro Bertero

Auto-generated profile, based on publicly available information

Alessandro Bertero

Molecular Biotechnology Center “Guido Tarone”, University of Torino, Torino, Italy

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2015 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
FSFotios Sampaziotis
Fotios Sampaziotis
MBMiguel Cardoso de Brito
Miguel Cardoso de Brito
PMPedro Madrigal
Pedro Madrigal
ABAlessandro Bertero
Alessandro Bertero
KSKourosh Saeb-Parsy
Kourosh Saeb-Parsy
LVLudovic Vallier
Ludovic Vallier
A protocol for generating biliary epithelial cells from human pluripotent stem cells facilitates disease modeling and drug screening. The study of biliary disease has been constrained by a lack of primary human cholangiocytes. Here we present an efficient, serum-free protocol for directed differentiation of human induced pluripotent stem cells into cholangiocyte-like cells (CLCs). CLCs show functional characteristics of cholangiocytes, including bile acids transfer, alkaline phosphatase activity, γ-glutamyl-transpeptidase activity and physiological responses to secretin, somatostatin and vascular endothelial growth factor. We use CLCs to model in vitro key features of Alagille syndrome, polycystic liver disease and cystic fibrosis (CF)-associated cholangiopathy. Furthermore, we use CLCs generated from healthy individuals and patients with polycystic liver disease to reproduce the effects of the drugs verapamil and octreotide, and we show that the experimental CF drug VX809 rescues the disease phenotype of CF cholangiopathy in vitro. Our differentiation protocol will facilitate the study of biological mechanisms controlling biliary development, as well as disease modeling and drug screening.

20 September 2017 in Nature
Verified
Journal Article
Open access
PDF file
NFNorah M. E. Fogarty
Norah M. E. Fogarty
AMAfshan McCarthy
Afshan McCarthy
KSKirsten E. Snijders
Kirsten E. Snijders
BPBenjamin E. Powell
Benjamin E. Powell
NKNada Kubikova
Nada Kubikova
KNKathy K. Niakan
Kathy K. Niakan
Despite their fundamental biological and clinical importance, the molecular mechanisms that regulate the first cell fate decisions in the human embryo are not well understood. Here we use CRISPR–Cas9-mediated genome editing to investigate the function of the pluripotency transcription factor OCT4 during human embryogenesis. We identified an efficient OCT4-targeting guide RNA using an inducible human embryonic stem cell-based system and microinjection of mouse zygotes. Using these refined methods, we efficiently and specifically targeted the gene encoding OCT4 (POU5F1) in diploid human zygotes and found that blastocyst development was compromised. Transcriptomics analysis revealed that, in POU5F1-null cells, gene expression was downregulated not only for extra-embryonic trophectoderm genes, such as CDX2, but also for regulators of the pluripotent epiblast, including NANOG. By contrast, Pou5f1-null mouse embryos maintained the expression of orthologous genes, and blastocyst development was established, but maintenance was compromised. We conclude that CRISPR–Cas9-mediated genome editing is a powerful method for investigating gene function in the context of human development.

28 February 2018 in Nature
Verified
Journal Article
Closed access
PDF file
ABAlessandro Bertero
Alessandro Bertero
SBStephanie Brown
Stephanie Brown
PMPedro Madrigal
Pedro Madrigal
AOAnna Osnato
Anna Osnato
DODaniel Ortmann
Daniel Ortmann
LVLudovic Vallier
Ludovic Vallier

3 July 2017 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
FSFotios Sampaziotis
Fotios Sampaziotis
AJAlexander W Justin
Alexander W Justin
OTOlivia C Tysoe
Olivia C Tysoe
SSStephen Sawiak
Stephen Sawiak
EGEdmund M Godfrey
Edmund M Godfrey
LVLudovic Vallier
Ludovic Vallier

1 May 2018 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
ALAndrea Leonard
Andrea Leonard
ABAlessandro Bertero
Alessandro Bertero
JPJoseph D. Powers
Joseph D. Powers
KBKevin M. Beussman
Kevin M. Beussman
SBShiv Bhandari
Shiv Bhandari
NSNathan Sniadecki
Nathan Sniadecki

2 August 2019 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
JBJohannes Bargehr
Johannes Bargehr
LOLay Ping Ong
Lay Ping Ong
MCMaria Colzani
Maria Colzani
HDHongorzul Davaapil
Hongorzul Davaapil
PHPeter Hofsteen
Peter Hofsteen
SSSanjay Sinha
Sanjay Sinha